Skip to content

Clinical trials

Completed Phase 2 trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Completed Country / region: Saudi Arabia Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20072
20083
20091
20102
20112
20147
20154
20163
20171
20187
20191
20205
20222
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imam Abdulrahman Bin Faisal University5
Novartis Pharmaceuticals4
King Faisal Specialist Hospital & Research Center3
King Faisal University3
Eli Lilly and Company2
Hoffmann-La Roche2
King Abdulaziz University2
Riyadh Colleges of Dentistry and Pharmacy2
Alaa Emara1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Glioblastoma2
Thalassemia2
Agnosia1
Anastomotic Leak1
Anemia, Aplastic1
Anemia, Sickle Cell1
Asthma1
Biliary Tract Neoplasms1
Brain Neoplasms1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.